FDA Approved: SPRAVATO — Supplemental Application (Janssen Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Janssen's supplemental application for SPRAVATO (esketamine hydrochloride), updating its labeling to reflect the approved supplementary indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

SUPPL AP for SPRAVATO (ESKETAMINE HYDROCHLORIDE)